MAPK signaling regulates c-MYC for melanoma cell adaptation to asparagine restriction

EMBO Rep. 2021 Mar 3;22(3):e51436. doi: 10.15252/embr.202051436. Epub 2021 Feb 8.

Abstract

Amino acid restriction is among promising potential cancer treatment strategies. However, cancer cells employ a multitude of mechanisms to mount resistance to amino acid restriction, which impede the latter's clinical development. Here we show that MAPK signaling activation in asparagine-restricted melanoma cells impairs GSK3-β-mediated c-MYC degradation. In turn, elevated c-MYC supports ATF4 translational induction by enhancing the expression of the amino acid transporter SLC7A5, increasing the uptake of essential amino acids, and the subsequent maintenance of mTORC1 activity in asparagine-restricted melanoma cells. Blocking the MAPK-c-MYC-SLC7A5 signaling axis cooperates with asparagine restriction to effectively suppress melanoma cell proliferation. This work reveals a previously unknown axis of cancer cell adaptation to asparagine restriction and informs mechanisms that may be targeted for enhanced therapeutic efficacy of asparagine limiting strategies.

Keywords: ATF4; MAPK; c-MYC; mTORC1; melanoma.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asparagine*
  • Cell Line, Tumor
  • Cell Proliferation
  • Glycogen Synthase Kinase 3
  • Humans
  • Mechanistic Target of Rapamycin Complex 1 / genetics
  • Mechanistic Target of Rapamycin Complex 1 / metabolism
  • Melanoma* / genetics
  • Proto-Oncogene Proteins c-myc / genetics
  • Proto-Oncogene Proteins c-myc / metabolism
  • Signal Transduction

Substances

  • Proto-Oncogene Proteins c-myc
  • Asparagine
  • Mechanistic Target of Rapamycin Complex 1
  • Glycogen Synthase Kinase 3